NCT03886272View on ClinicalTrials.gov

A Study in Healthy Men and Women to Test if Taking Different Formulations of BI 730357 Tablets Influences the Amount of BI 730357 in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

April 11, 2019

Primary Completion Date

June 21, 2019

Study Completion Date

June 21, 2019

Conditions
Healthy
Interventions
DRUG

BI 730357 (Test)

tablet

DRUG

BI 730357 (Reference)

tablet

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY